372 related articles for article (PubMed ID: 29346736)
1. Light-Activatable Red Blood Cell Membrane-Camouflaged Dimeric Prodrug Nanoparticles for Synergistic Photodynamic/Chemotherapy.
Pei Q; Hu X; Zheng X; Liu S; Li Y; Jing X; Xie Z
ACS Nano; 2018 Feb; 12(2):1630-1641. PubMed ID: 29346736
[TBL] [Abstract][Full Text] [Related]
2. Photodynamic PEG-coated ROS-sensitive prodrug nanoassemblies for core-shell synergistic chemo-photodynamic therapy.
Sun B; Chen Y; Yu H; Wang C; Zhang X; Zhao H; Chen Q; He Z; Luo C; Sun J
Acta Biomater; 2019 Jul; 92():219-228. PubMed ID: 31078764
[TBL] [Abstract][Full Text] [Related]
3. Photolytic Removal of Red Blood Cell Membranes Camouflaged on Nanoparticles for Enhanced Cellular Uptake and Combined Chemo-Photodynamic Inhibition of Cancer Cells.
Liu Y; Wen N; Li K; Li M; Qian S; Li S; Jiang T; Wang T; Wu Y; Liu Z
Mol Pharm; 2022 Mar; 19(3):805-818. PubMed ID: 35148115
[TBL] [Abstract][Full Text] [Related]
4. PBPK modeling-based optimization of site-specific chemo-photodynamic therapy with far-red light-activatable paclitaxel prodrug.
Li M; Nguyen L; Subramaniyan B; Bio M; Peer CJ; Kindrick J; Figg WD; Woo S; You Y
J Control Release; 2019 Aug; 308():86-97. PubMed ID: 31299262
[TBL] [Abstract][Full Text] [Related]
5. ROS-responsive nanoparticles based on amphiphilic hyperbranched polyphosphoester for drug delivery: Light-triggered size-reducing and enhanced tumor penetration.
Jin H; Zhu T; Huang X; Sun M; Li H; Zhu X; Liu M; Xie Y; Huang W; Yan D
Biomaterials; 2019 Aug; 211():68-80. PubMed ID: 31096162
[TBL] [Abstract][Full Text] [Related]
6. NIR-triggered high-efficient photodynamic and chemo-cascade therapy using caspase-3 responsive functionalized upconversion nanoparticles.
Zhao N; Wu B; Hu X; Xing D
Biomaterials; 2017 Oct; 141():40-49. PubMed ID: 28666101
[TBL] [Abstract][Full Text] [Related]
7. Far-Red Light-Activatable Prodrug of Paclitaxel for the Combined Effects of Photodynamic Therapy and Site-Specific Paclitaxel Chemotherapy.
Thapa P; Li M; Bio M; Rajaputra P; Nkepang G; Sun Y; Woo S; You Y
J Med Chem; 2016 Apr; 59(7):3204-14. PubMed ID: 26974508
[TBL] [Abstract][Full Text] [Related]
8. A Paclitaxel Prodrug Activatable by Irradiation in a Hypoxic Microenvironment.
Zhou S; Hu X; Xia R; Liu S; Pei Q; Chen G; Xie Z; Jing X
Angew Chem Int Ed Engl; 2020 Dec; 59(51):23198-23205. PubMed ID: 32852145
[TBL] [Abstract][Full Text] [Related]
9. Light-activatable dual-source ROS-responsive prodrug nanoplatform for synergistic chemo-photodynamic therapy.
Yang B; Wang K; Zhang D; Sun B; Ji B; Wei L; Li Z; Wang M; Zhang X; Zhang H; Kan Q; Luo C; Wang Y; He Z; Sun J
Biomater Sci; 2018 Nov; 6(11):2965-2975. PubMed ID: 30255178
[TBL] [Abstract][Full Text] [Related]
10. Light-activatable Chlorin e6 (Ce6)-imbedded erythrocyte membrane vesicles camouflaged Prussian blue nanoparticles for synergistic photothermal and photodynamic therapies of cancer.
Sun L; Li Q; Hou M; Gao Y; Yang R; Zhang L; Xu Z; Kang Y; Xue P
Biomater Sci; 2018 Oct; 6(11):2881-2895. PubMed ID: 30192355
[TBL] [Abstract][Full Text] [Related]
11. Low-power and low-drug-dose photodynamic chemotherapy via the breakdown of tumor-targeted micelles by reactive oxygen species.
Seah GL; Yu JH; Yang MY; Kim WJ; Kim JH; Park K; Cho JW; Kim JS; Nam YS
J Control Release; 2018 Sep; 286():240-253. PubMed ID: 30071252
[TBL] [Abstract][Full Text] [Related]
12. Self-facilitated ROS-responsive nanoassembly of heterotypic dimer for synergistic chemo-photodynamic therapy.
Luo C; Sun B; Wang C; Zhang X; Chen Y; Chen Q; Yu H; Zhao H; Sun M; Li Z; Zhang H; Kan Q; Wang Y; He Z; Sun J
J Control Release; 2019 May; 302():79-89. PubMed ID: 30946853
[TBL] [Abstract][Full Text] [Related]
13. Binary dimeric prodrug nanoparticles for self-boosted drug release and synergistic chemo-photodynamic therapy.
Zhang Y; Pei Q; Yue Y; Xie Z
J Mater Chem B; 2022 Feb; 10(6):880-886. PubMed ID: 35043826
[TBL] [Abstract][Full Text] [Related]
14. Chemo-photodynamic therapy with light-triggered disassembly of theranostic nanoplatform in combination with checkpoint blockade for immunotherapy of hepatocellular carcinoma.
Xu J; Zheng Q; Cheng X; Hu S; Zhang C; Zhou X; Sun P; Wang W; Su Z; Zou T; Song Z; Xia Y; Yi X; Gao Y
J Nanobiotechnology; 2021 Oct; 19(1):355. PubMed ID: 34717654
[TBL] [Abstract][Full Text] [Related]
15. ROS-sensitive biomimetic nanocarriers modulate tumor hypoxia for synergistic photodynamic chemotherapy.
Liu H; Jiang W; Wang Q; Hang L; Wang Y; Wang Y
Biomater Sci; 2019 Aug; 7(9):3706-3716. PubMed ID: 31187794
[TBL] [Abstract][Full Text] [Related]
16. NIR-Light-Activated Combination Therapy with a Precise Ratio of Photosensitizer and Prodrug Using a Host-Guest Strategy.
Chen H; Zeng X; Tham HP; Phua SZF; Cheng W; Zeng W; Shi H; Mei L; Zhao Y
Angew Chem Int Ed Engl; 2019 Jun; 58(23):7641-7646. PubMed ID: 30980463
[TBL] [Abstract][Full Text] [Related]
17. Cascade-amplifying synergistic effects of chemo-photodynamic therapy using ROS-responsive polymeric nanocarriers.
Sun CY; Cao Z; Zhang XJ; Sun R; Yu CS; Yang X
Theranostics; 2018; 8(11):2939-2953. PubMed ID: 29896295
[TBL] [Abstract][Full Text] [Related]
18. Quantitative modeling of the dynamics and intracellular trafficking of far-red light-activatable prodrugs: implications in stimuli-responsive drug delivery system.
Li M; Thapa P; Rajaputra P; Bio M; Peer CJ; Figg WD; You Y; Woo S
J Pharmacokinet Pharmacodyn; 2017 Dec; 44(6):521-536. PubMed ID: 28913666
[TBL] [Abstract][Full Text] [Related]
19. Photo-responsive hollow silica nanoparticles for light-triggered genetic and photodynamic synergistic therapy.
Lin X; Wu M; Li M; Cai Z; Sun H; Tan X; Li J; Zeng Y; Liu X; Liu J
Acta Biomater; 2018 Aug; 76():178-192. PubMed ID: 30078423
[TBL] [Abstract][Full Text] [Related]
20. Bioactivatable reactive oxygen species-sensitive nanoparticulate system for chemo-photodynamic therapy.
Kim Y; Uthaman S; Pillarisetti S; Noh K; Huh KM; Park IK
Acta Biomater; 2020 May; 108():273-284. PubMed ID: 32205212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
